StockWatch
·
Medicinal Chemicals & Botanical Products
MergerJun 15, 2026, 01:21 PM

Vireo Growth to Acquire C21 Investments; Expands Nevada Footprint

AI Summary

C21 Investments Inc. announced a definitive arrangement agreement to be acquired by Vireo Growth Inc. C21 shareholders will receive 0.023052 of a Vireo subordinate voting share for each C21 share. This acquisition will significantly expand Vireo's presence in Nevada, adding 3 dispensaries and 104,000 sq. ft. of cultivation and production capacity, bringing Vireo's total to approximately 15 dispensaries and 158,000 sq. ft. in the state. The C21 Board unanimously approved the transaction, which is subject to shareholder, court, and regulatory approvals.

Key Highlights

  • Vireo Growth Inc. to acquire C21 Investments Inc. via definitive arrangement agreement.
  • C21 shareholders to receive 0.023052 Vireo subordinate voting shares per C21 share.
  • Acquisition adds 3 dispensaries and 104,000 sq. ft. cultivation capacity in Nevada.
  • Vireo's Nevada footprint to expand to 15 dispensaries and 158,000 sq. ft. post-acquisition.
  • C21 Board unanimously approved the transaction, recommending shareholder vote.
  • Transaction includes a US$3,000,000 termination fee payable by C21 in certain cases.
  • C21 shares expected to be delisted from CSE and OTCQX post-completion.